Yujiro Hata

Yujiro S.
Hata is the founder of IDEAYA Biosciences, Inc., founded in 2015, serving as Chairman, President & Chief Executive Officer.
Current jobs include Director at Experimed Bioscience, Inc., Independent Director at Enanta Pharmaceuticals, Inc. since 2021, Director-Moores Cancer Center at the University of California San Diego since 2015, and Director at Hexagon Bio, Inc. since 2024.
Former jobs include Director at Oscient Pharmaceuticals Corp., Independent Director at Xencor, Inc. from 2015 to 2022, Director at Expansion Therapeutics, Inc. from 2007 to 2021, VP-Corporate Development & Strategy at Onyx Pharmaceuticals, Inc. from 2010 to 2013, Principal at McKinsey & Co., Inc., Chief Business Officer & SVP-Business Development at Enanta Pharmaceuticals, Inc. from 2002 to 2010, Head-Business Development at ImClone LLC, Chief Operating Officer at Flexus Biosciences, Inc. from 2014 to 2015, and Chief Operating Officer at Rapt Therapeutics, Inc. from 2014 to 2015.
Education includes undergraduate studies at the University of Oxford and The Colorado College, and an MBA from The Wharton School of the University of Pennsylvania.